<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="1617">
<titleInfo>
<title>Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2021 , Vol 25 Issue 5</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher></publisher>
<dateIssued></dateIssued>
<issuance>monographic</issuance>
<edition>2021 , Vol 25 Issue 5</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Karya Tulis Ilmiah</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT: Pyrazoles and sulfonamides are ubiquitously classified as structural fragments in antimicrobial and
antimycobacterial agents. In this present study, a series of 14 pyrazole based sulfonamide derivatives (7-20) were
designed, synthesized regioisomeric structures were elucidated by spectroscopic methods. All target compounds were
evaluated for their in vitro antibacterial potential against selected Gram (+) and Gram (-) bacterial strains as well as for
their antimycobacterial activity. The bioactivity results demonstrated that all compounds showed selective antibacterial
activity against B. subtilis with MIC values of 1-125 &mu;g/mL. Especially, 1-[(2,4-dichlorophenyl)methyl]-N-(4-
methoxybenzenesulfonyl)-3-methyl-1H-pyrazole-5-carboxamide (9), 1-[(2,4-Dichlorophenyl)methyl]-N-(4-
fluorobenzenesulfonyl)-3-methyl-1H-pyrazole-5-carboxamide (10), N-(3,5-Dichlorobenzenesulfonyl)-1-[(2,4-
dichlorophenyl)methyl]-3-methyl-1H-pyrazole-5-carboxamide (11) and 1-[(2,4-dichlorophenyl)methyl]-N-(4-
fluorobenzenesulfonyl)-5-methyl-1H-pyrazole-3-carboxamide (17) displayed the highest antibacterial activity against
B. subtilis with MIC values of 1 &mu;g/mL, which were more effective compared to the reference chloramphenicol. As a
conclusion, the snythesized new pyrazole sulfonamides stand out as promising antimicrobial agents for further
development.
KEYWORDS: Pyrazole; sulfonamide; regioisomer; antibacterial activity; antimycobacterial activity.</note>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0081</numerationAndChronology>
<sublocation>Perpus.Akfarsam (jurnal Internasioan)</sublocation>
<shelfLocator>615 MAR b</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="1692" url="https://drive.google.com/file/d/1-nonE-mTJUyBHUaGko62vvPKYoqE-NjD/view?usp=sharing" path="/https://drive.google.com/file/d/1-nonE-mTJUyBHUaGko62vvPKYoqE-NjD/view?usp=sharing" mimetype="text/uri-list">Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2021 , Vol 25 Issue 5</slims:digital_item>
</slims:digitals><recordInfo>
<recordIdentifier>1617</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2022-07-20 08:34:03</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2022-07-20 08:36:43</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>